Leadership Overview
Pierre Fabre has 7 executives leading key functions including finance, marketing, and operations.
Driven by a commitment to innovation, Pierre Fabre is dedicated to advancing pharmaceuticals and dermo-cosmetics, impacting global health and well-being through its specialized divisions and market-leading brands.
Driven by a commitment to innovation, Pierre Fabre is dedicated to advancing pharmaceuticals and dermo-cosmetics, impacting global health and well-being through its specialized divisions and market-leading brands.
Leadership Roles at Pierre Fabre
Juan Li - Chief Financial Officer
Juan Li, the Chief Financial Officer at Pierre Fabre, directs the company's financial strategy and operations. Overseeing all fiscal activities, Li ensures robust financial planning, accurate reporting, and effective resource allocation across the organization. This leadership role involves managing budgets, optimizing financial performance, and driving profitability in alignment with Pierre Fabre's pharmaceutical and dermo-cosmetics objectives. Li's expertise supports the company's growth initiatives and market expansion, particularly within the European and Asian dermo-cosmetics sectors. The Chief Financial Officer's responsibilities extend to risk management and ensuring compliance with financial regulations, safeguarding the company's assets and long-term financial health. By maintaining strong financial discipline, Juan Li contributes directly to the stability and strategic advancement of Pierre Fabre's global operations.
Amanda de Lima Ventura - Chief Financial Officer (Brazil)
Amanda de Lima Ventura, the Chief Financial Officer (Brazil) at Pierre Fabre, manages the financial operations and strategic planning for the Brazilian market. Overseeing all fiscal aspects within Brazil, Ventura ensures accurate financial reporting, budget management, and the optimization of financial resources to support local business objectives. This critical role involves aligning financial strategies with the company's pharmaceutical and dermo-cosmetics goals specific to the Americas region. The Chief Financial Officer (Brazil) works to enhance profitability and drive sustainable growth by identifying market opportunities and managing financial risks effectively. Amanda de Lima Ventura's leadership ensures financial integrity and supports the expansion of Pierre Fabre's presence in Brazil, contributing to the overall success of the company's operations in the Americas.
Jean Bueno - Chief Marketing Officer
Jean Bueno, the Chief Marketing Officer at Pierre Fabre, architects the global marketing strategies for the company's diverse portfolio. Directing all marketing initiatives, Bueno focuses on enhancing brand visibility and market penetration for both the Pharmaceuticals and Dermo-cosmetics divisions. This includes spearheading campaigns for the flagship Eau Thermale Avène brand, a leader in Europe and Asia. The Chief Marketing Officer's role involves deep market analysis, consumer insights, and the development of innovative promotional activities to drive sales and customer engagement. Bueno collaborates closely with product development and sales teams to ensure marketing efforts align with business objectives and market demands. By shaping brand perception and communicating value propositions effectively, Jean Bueno significantly influences Pierre Fabre's competitive positioning and revenue generation across key international markets.
Denner Evangelio - Director, Industrial Operations Cdmo (Brazil) & Chief Marketing Officer & Director (Americas)
Denner Evangelio, the Director, Industrial Operations Cdmo (Brazil) & Chief Marketing Officer & Director (Americas) at Pierre Fabre, directs multifaceted operations across the Americas. Evangelio oversees industrial operations for Contract Development and Manufacturing Organization (CDMO) services in Brazil, ensuring efficient production and quality standards. Concurrently, this executive drives marketing strategies and overall business direction for the Americas region, aligning with Pierre Fabre's global pharmaceutical and dermo-cosmetics objectives. The scope of this role encompasses optimizing supply chains, enhancing market presence, and fostering business development throughout the Americas. Denner Evangelio's leadership integrates operational excellence with strategic market growth, significantly contributing to Pierre Fabre's expansion and success in key international territories.
Hai Chi - Chief Finance Officer
Hai Chi, the Chief Finance Officer at Pierre Fabre, oversees the comprehensive financial management and strategic fiscal planning for the organization. Directing all financial functions, Chi ensures the integrity of financial reporting, manages capital allocation, and drives financial performance improvements. This executive role is pivotal in supporting Pierre Fabre's dual focus on pharmaceuticals and dermo-cosmetics, guiding investment decisions and resource deployment to achieve corporate objectives. The Chief Finance Officer's responsibilities include risk assessment, financial forecasting, and ensuring compliance with global financial regulations. By maintaining rigorous financial oversight, Hai Chi contributes to the company's stability, operational efficiency, and sustained growth across its international markets.
Paulo Ferraz - Country Chief Finance Officer
Paulo Ferraz, the Country Chief Finance Officer at Pierre Fabre, leads the financial strategy and operations within a specific country. Ferraz directs all fiscal activities, ensuring robust financial planning, accurate reporting, and effective resource management to support local business objectives. This role is crucial for optimizing financial performance and driving profitability in alignment with Pierre Fabre's pharmaceutical and dermo-cosmetics goals. The Country Chief Finance Officer's responsibilities include managing budgets, overseeing financial controls, and contributing to strategic decision-making at the country level. By ensuring financial discipline and compliance, Paulo Ferraz plays a key part in strengthening Pierre Fabre's market position and contributing to its overall financial health and growth.
Yann Dugenou - Drh
Yann Dugenou, the Drh at Pierre Fabre, directs the human resources strategy and operations for the company. Dugenou oversees talent management, organizational development, and employee relations, ensuring alignment with Pierre Fabre's business objectives in pharmaceuticals and dermo-cosmetics. This leadership role focuses on cultivating a skilled workforce, fostering a positive corporate culture, and implementing HR policies that support employee growth and engagement. The Drh's responsibilities include recruitment, compensation, benefits, and ensuring compliance with labor laws across the organization. By championing human capital development, Yann Dugenou significantly contributes to Pierre Fabre's operational effectiveness and its ability to achieve strategic goals through its people.
Explore Leadership Teams in Manufacturing
GSK plc is a British multinational pharmaceutical and biotechnology company headquartered in London, United Kingdom. Established in 2000 through the merger of Glaxo Wellcome and SmithKline Beecham, GSK is the tenth-largest pharmaceutical company globally. The company discovers, develops, manufactures, and delivers medicines and vaccines with a research and development focus on four primary therapeutic areas: respiratory, immunology and inflammation, oncology, HIV, and infectious diseases. GSK's product portfolio includes specialty medicines, vaccines, and general medicines targeting conditions such as HIV, respiratory diseases, cancer, immuno-inflammation, anti-viral, central nervous system disorders, metabolic conditions, cardiovascular disease, urogenital conditions, anti-bacterial treatments, dermatology, and rare diseases. The company also offers over-the-counter products for pain relief, oral health, nutrition, skin health, and gastrointestinal diseases. GSK has a primary listing on the London Stock Exchange and is a constituent of the FTSE 100 Index. In July 2024, the company moved its global headquarters to New Oxford Street in central London, positioning itself within the city's Knowledge Quarter near world-class science and academic institutions including the Francis Crick Institute and King's College London. The new headquarters houses approximately 3,000 employees including the global leadership team and teams supporting research and development, supply chain, commercial operations, and corporate functions. GSK sells its products through wholesalers, pharmacies, hospitals, physicians, and other healthcare groups globally, aiming to positively impact the health of 2.5 billion people by the end of the decade.
Company Leadership MD
CJ
GN
Founded in 1989, Vertex Pharmaceuticals is a global biotechnology company focused on the discovery, development and commercialization of drugs for a range of serious diseases. Located in Boston, Massachusetts.
Company Leadership
SF
DD
Sentiss Pharma is a niche pharmaceutical company that specializes in providing high-quality ophthalmic, inhalation, otic, and nasal drop products. Established in 1990, the company is dedicated to delivering innovative healthcare solutions globally while maintaining a strong commitment to quality and social responsibility. Their product portfolio includes a range of specialty products aimed at improving health outcomes. Sentiss is recognized as a Great Place to Work in India for nine consecutive years, reflecting its focus on employee satisfaction and community engagement.
Company Leadership DB
SO
Asymchem Inc. is a leading Contract Development and Manufacturing Organization (CDMO) dedicated to serving global pharmaceutical companies. They specialize in innovative green solutions as well as advanced drug development and manufacturing services. Their target clients primarily consist of pharmaceutical companies requiring comprehensive support in the areas of drug production and development. Asymchem's commitment to sustainability and development positions it as a preferred partner in the pharmaceutical sector.
Company Leadership HH
AK
EH